🌱 KidneyEnergy.com

← brief for 2026-11-12 · Regeneration & devices

The STAT3/JAK2 Signaling Pathway in Renal Fibrosis: Mechanistic Insights and Advances in Targeted Intervention.

Paper D Peer reviewed Preclinical

Key takeaways

This review explains how a specific cell signal, called STAT3, drives kidney scarring. Most of the evidence comes from animal and cell studies, not people yet. It highlights potential drug targets for reversing scarring. This is early science that may lead to new treatments in the future.

Who did this work

Yu Y · Lv J · Chai Y · Wang X · Yu M

Source

Paper · PubMed, fibrosis reversal · 2026 Nov 7
https://pubmed.ncbi.nlm.nih.gov/43017214/